![anesthesia glp-1 news π΄ RAs and Anesthesia: 2025 Consensus Update: Patients on GLP-1 receptor agonists (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before if asymptomatic, with extended fasting to reduce aspiration risk GLP-1RAs-and-Anesthesia-A-Guide-to-Safe-Practices [Autosaved].pptx](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=804715105415068)
anesthesia glp-1 news π΄ RAs and Anesthesia: 2025 Consensus Update: Patients on GLP-1 receptor agonists (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before if asymptomatic, with extended fasting to reduce aspiration risk GLP-1RAs-and-Anesthesia-A-Guide-to-Safe-Practices [Autosaved].pptx
USD21.30
USD64.30
Pay in 4 interest-free payments of $5.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 18 - Aug 23
![anesthesia glp-1 news RAs and Anesthesia: 2025 Consensus Update: Patients on GLP-1 receptor agonists (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before if asymptomatic, with extended fasting to reduce aspiration risk GLP-1RAs-and-Anesthesia-A-Guide-to-Safe-Practices [Autosaved].pptx](https://image.slidesharecdn.com/glp-1ras-and-anesthesia-a-guide-to-safe-practicesautosaved-251022071155-f92d8e2f/75/GLP-1RAs-and-Anesthesia-A-Guide-to-Safe-Practices-Autosaved-pptx-10-2048.jpg)
![anesthesia glp-1 news RAs and Anesthesia: 2025 Consensus Update: Patients on GLP-1 receptor agonists (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before if asymptomatic, with extended fasting to reduce aspiration risk GLP-1RAs-and-Anesthesia-A-Guide-to-Safe-Practices [Autosaved].pptx](https://media.wzzm13.com/assets/WZZM/images/91e60b55-27bc-4104-8878-63c7568be23f/20260728T221709/91e60b55-27bc-4104-8878-63c7568be23f_1920x1080.jpg)
![anesthesia glp-1 news RAs and Anesthesia: 2025 Consensus Update: Patients on GLP-1 receptor agonists (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before if asymptomatic, with extended fasting to reduce aspiration risk GLP-1RAs-and-Anesthesia-A-Guide-to-Safe-Practices [Autosaved].pptx](https://www.generalsurgerynews.com/aimages/2025/GSN0525_020a_5497_425.jpg)
![anesthesia glp-1 news RAs and Anesthesia: 2025 Consensus Update: Patients on GLP-1 receptor agonists (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before if asymptomatic, with extended fasting to reduce aspiration risk GLP-1RAs-and-Anesthesia-A-Guide-to-Safe-Practices [Autosaved].pptx](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3870482896541006645)
![anesthesia glp-1 news RAs and Anesthesia: 2025 Consensus Update: Patients on GLP-1 receptor agonists (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before if asymptomatic, with extended fasting to reduce aspiration risk GLP-1RAs-and-Anesthesia-A-Guide-to-Safe-Practices [Autosaved].pptx](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13741-026-00662-9/MediaObjects/13741_2026_662_Fig1_HTML.png)
![anesthesia glp-1 news RAs and Anesthesia: 2025 Consensus Update: Patients on GLP-1 receptor agonists (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before if asymptomatic, with extended fasting to reduce aspiration risk GLP-1RAs-and-Anesthesia-A-Guide-to-Safe-Practices [Autosaved].pptx](https://media.oralhealthgroup.com/uploads/2024/02/Pynn-fig1.png)
